Safety and clinical activity of target-preserving anti-CTLA-4 antibody ONC-392 as monotherapy in NSCLC patients who progressed on PD(L)1-targeted immunotherapy - Carbone, David Paul; McKean, Meredith; Balaraman, Rama; Shah, Satish; Arrowsmith, Edward; Peguero, Julio Antonio; Joshi, Rohit; He, Aiwu Ruth; Milillo, Adriana; Hamm, John Turner; Goldstein, Mark Gregory; Li, Zihai; et al. (Journal of clinical oncology, 2023)